Why low-cost ketamine is still inaccessible to many with severe depression

ketamine

  • providing better commercial incentives
  • boosting funding for integrated and translational research
  • reducing regulatory hurdles
  • optimizing clinical trial procedures, and
  • fostering broader collaboration across sectors and borders

Remarkable results

Source: Read Full Article